Result
€517,589 ▼ 80.3%
The result fell in 2025: different schema filed.
DERMAX
Lifetime
9 annual accounts with figures on one time axispeak €3.3m (2024)
€1.2m▼ 63.6%
lowest -€742,845 (2019)
€517,589▼ 80.3%
peak €5.3m (2025)
€5.3m▲ 10.8%
€414,335▼ 76.4%
Board6 names since 2016
-
Owners
100%
Documentsfilings and deeds
07-07-202624 days before the deadline
2025abbreviated format
Gross margin from €3.3m to €1.2mResult from €2.6m to €517,589Appointment: (statutory auditor) 26-09Permanent representative: 05-03Debts from €1.8m to €414,335Cash from €257,494 to €168,229
Key points
from the 2025 annual accountsPayment terms
185 days to suppliers
DERMAX pays its suppliers 114,672 days earlier than in 2024.
Liquidity
7.28 was 2.42 in 2024
Short-term debts fell from €1.6m to €414,335.
Filings
9 annual accounts 3 late
The 2023 accounts came latest: 107 days after the end of the period.
At the same address
47 companies
Position in the sector
€5.3m
More equity than 95% of companies in wholesale trade. Sector median €493,293 · 10,732 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,783 companies had the same profile as DERMAX has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,783 companies, not a prediction for DERMAX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
last known boardDirector, until 2020
Director, last mentioned in 2020
Director, until 2020
Daily manager, last mentioned in 2020
Auditor,
- 100%equity €87.2m (2025) · 2025 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0667730677
Appointment: (statutory auditor)
Permanent representative: · General meeting of 10-06-2025 · Gazette deed
Permanent representative:
Gazette deed
Reappointment: (statutory auditor)
General meeting of 15-09-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DERMAX Liège | €5.7m | €1.2m | 92.8% | - |
| Corin Belgium Aarschot | €4.4m | €1.3m | 17.3% | 7 |
| Mobio Lokeren | €5.3m | €1.2m | 15.8% | 6.9 |
| AAGATO MEDICAL Ghent | €3.9m | €1.4m | 28.6% | 5.8 |
| Covarmed Kortrijk | €4.9m | €1.9m | 63.1% | 15.6 |
| OPHTALMO SURGICAL Oudenaarde | €4.6m | €0.8m | 8.2% | 6.9 |
| MOTION MEDICAL Sint-Genesius-Rode | €7.1m | €0.8m | 52.1% | 5.5 |
These companies have the same main activity as DERMAX: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €3.9m and €7.1m, founded between 2015 and 2018.
Official details
Source: KBO- Status
- Active since 15-12-2016Normal situation
- Registered office
- 48 active companies are registered at this address4 started in the 12 months before. Source: KBO register, as of 12 November 2026.
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
- Establishment unit
- 2.262.638.6284000 Liège, since 01-03-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 21-10-2025
Annual accounts 2025
- €5.7m▼ 12.6%
- Filing
- Filed on 07-07-2026, 24 days before the end of the filing period
Insights on DERMAX
DERMAX files the abbreviated format. That format states no turnover. The gross margin rose from -€15,714 in 2017 to €1.2m in 2025.
holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DERMAX
- What is the company number of DERMAX?
- The company number of DERMAX is 0667.730.677. The VAT number is the same number with BE in front: BE 0667.730.677.
- Where is DERMAX based?
- The registered office is at Boulevard de Patience et Beaujonc 3, 4000 Liège.Company details
- What does DERMAX do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of DERMAX?
- DERMAX is a public limited company (NV).
- When was DERMAX founded?
- DERMAX was founded on 15-12-2016.
- Is DERMAX still active?
- Yes, DERMAX is an active enterprise in the KBO register.
- What is the turnover of DERMAX?
- The turnover of DERMAX was €1.6m in financial year 2025, according to the filed annual accounts.Financials
- Is DERMAX profitable?
- In financial year 2025, DERMAX made a profit of €517,589.
- Where can I find the annual accounts of DERMAX?
- DERMAX filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DERMAX due?
- DERMAX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.